Page URL:
CONTENTS Issue #306
Why treat PGD for late onset disorders differently?
BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read

You are currently viewing the Alert version of the BioNews email newsletter.

Click the tab above to view the Full Text version

Welcome to BioNews by email, published by the Progress Educational Trust, providing you with news, comment and reviews on genetics, assisted conception, embryo/stem cell research and related areas. 

Visit the BioNews website at where you can subscribe for free to receive BioNews by email in one of three formats, and search the archive of more than 8,000 articles.

Why treat PGD for late onset disorders differently?
4 May 2005 - by Mohammed Taranissi
Like so many areas of new reproductive and genetic technology, PGD for susceptibility and late onset disorders needs careful attention. It raises some unique questions, and the recent decision of the Human Fertilisation and Embryology Authority (HFEA) to license PGD for bowel cancer has attracted much criticism from those who... [Read More]
Law Lords back 'saviour siblings'
28 April 2005 - by BioNews
The UK's House of Lords has ruled that the decision taken by the Human Fertilisation and Embryology Authority (HFEA) to allow the Hashmi family to try to create a 'saviour sibling' was lawful. The highest court in the UK heard the appeal case of Quintavalle (On behalf of Comment on... [Read More]
US panel proposes stem cell guidelines
28 April 2005 - by BioNews
A panel of the US National Academies of science has released a report detailing proposed voluntary ethical guidelines to be followed by human embryonic stem (ES) cell researchers. The ten-member panel makes more than 50 recommendations, including the primary recommendation that an ethical oversight committee is set up in each... [Read More]
Massachusetts one step closer to stem cell law
28 April 2005 - by BioNews
The state Senate of Massachusetts, US, has passed an amended bill regulating human embryonic stem (ES) cell research and cloning. Sponsored by Senate President Robert Travaglini, the bill, which was passed by 34 votes to two, would allow embryos to be cloned for medical research purposes, but prohibit human reproductive... [Read More]
Australia to cut IVF funding
28 April 2005 - by BioNews
The Australian federal government is planning to cut back on funding for IVF in its budget next month. It is considering placing a cap on the number of Medicare-funded IVF treatments to a maximum of three for women over 42 and three per year for women below that age. The... [Read More]
Gene discovery sheds light on sleep requirement
29 April 2005 - by BioNews
US researchers have identified a single gene alteration that controls the amount of time a fruit fly sleeps for. The discovery could lead to new ways of treating sleep disturbances in people, say the scientists, who are based at the University of Wisconsin Medical School. The findings, published in the... [Read More]
Genetic screening for iron overload disorder suggested
29 April 2005 - by BioNews
Testing people to identify those at risk of developing a preventable genetic condition does not make them more anxious, Australian researchers have found. The team investigated the effect of carrying out a genetic test for haemochromatosis, a disorder that causes the body to absorb too much iron. They found that... [Read More]
Call to track health of embryo test babies
29 April 2005 - by BioNews
All centres carrying out preimplantation genetic diagnosis (PGD) should be following up the resulting babies to track any long term effects on their health, a UK doctor has said. Peter Braude, of Kings College London, one of eight UK centres offering the treatment, called for more long-term studies at a... [Read More]
Celera to stop charging for genome data
29 April 2005 - by BioNews
US firm Celera Genomics is to discontinue its subscription business, through which it charges scientists to access its genome data. The company caused controversy when it published its version of the entire human genetic code, in February 2001. In contrast to the publicly-funded human genome effort, Celera did not make... [Read More]

Advertising in BioNews

BioNews is read by around 18,000 people every week. Our readership is predominantly in the UK, but we have subscribers in 44 countries. That is a lot of people with an interest in assisted conception, genetics, embryo/stem cell research and related areas.

Advertisements (up to 300 words in length) start from as little as £75, making BioNews a very cost effective way to reach your target audience.

The Progress Educational Trust can personally vouch for the service, as the charity has itself successfully engaged members of staff via BioNews. Why not save money by recruiting through BioNews, and help keep BioNews FREE at the same time?

If you would like further information about advertising a job or opportunity in BioNews, please contact Sarah Norcross on +44 (0)20 7278 7870 or at

Sarah Norcross
Director, Progress Educational Trust
140 Gray's Inn Road
London, WC1X 8AX